Ryszard Pluta | Medicine | Best Researcher Award

Published on by Mechanics Awards

Prof. Dr. Ryszard Pluta | Medicine | Best Researcher Award 

Professor, at Department of Pathophysiology, Medical University of Lublin, Poland,

Professor Ryszard Pluta, M.D., Ph.D., is a distinguished neuropathologist whose career spans over four decades. He earned his M.D. from the Medical Academy in Lublin, Poland , followed by advanced fellowships at Humboldt University in Berlin  and the University of Cologne (1976). He earned his Ph.D. from the Polish Academy of Sciences in Warsaw in 1983, was promoted to Associate Professor in 1992, and served as Full Professor at the Mossakowski Medical Research Institute (2004–2022). Internationally recognized, he held postdoctoral fellowships at the U.S. National Institutes of Health (1986–1988) and New York State Institute for Basic Research (1988–1989), and has been Visiting Professor at prestigious institutions in the U.S. and Europe. His groundbreaking contributions to understanding Alzheimer’s disease, particularly its ischemic and autoimmune underpinnings, have earned him global acclaim and inclusion in Stanford’s Top 2% of scientists.

Professional Profile

Scopus

ORCID

🎓 Education

Ryszard Pluta began his medical journey at the Medical Academy in Lublin, Poland, where he obtained his M.D. between 1971 and 1977. Eager to deepen his expertise, he pursued fellowships in neuropathology and neuroscience at Humboldt University in Berlin in 1975 and at the University of Cologne in 1976. His academic pursuits led him to the Polish Academy of Sciences in Warsaw, where he earned a Ph.D. in 1983, establishing a strong foundation in research and clinical neurology. In 1992, he defended his Associate Professor thesis and later achieved Full Professor status in 2004 at the Mossakowski Medical Research Institute, where he served until 2022. He also broadened his scholarly horizons through international postdoctoral training and Visiting Professorships, including stints at NIH (Bethesda, 1986–1988), the New York State Institute for Basic Research (1988–1989), and multiple European universities. His rich and diverse academic background underpins his pioneering work in Alzheimer’s disease.

💼 Experience 

Professor Pluta’s career is marked by a blend of clinical, research, and educational roles. From 2004 to 2022, he led as Full Professor at the Mossakowski Medical Research Institute, Polish Academy of Sciences in Warsaw, steering groundbreaking neuroscience research. Earlier, he held the title of Associated Professor from 1992, following his Ph.D. achievement in 1983. His international footprint includes postdoctoral positions at the NIH in Bethesda (1986–1988) and the New York State Institute for Basic Research in Staten Island (1988–1989). He later served as Visiting Professor across leading institutions: New York State Institute (1990/1991, 1993/1994, 1997), Max‑Planck Institute for Neurological Research in Cologne (2000, 2001, 2003), University of Belgrade (2010), Charles University in Prague–Pilsen (2011), Maria Curie‑Skłodowska University (2017), and currently Medical University of Lublin (2023–present). Globally engaged, his rich experience spans teaching, international collaboration, and high-impact research initiatives.

🔬 Research Interest 

Professor Pluta’s primary research interest lies in unraveling the mechanisms of Alzheimer’s disease through an ischemic lens. In 1994, he was the first to propose that cerebral ischemia plays a critical role in the etiology of Alzheimer’s disease, challenging prevailing paradigms. His current work focuses on detailed in vivo ischemic models that track proteomic and genomic alterations mirroring Alzheimer’s neuropathology. He investigates the sequence of molecular events—gene expression changes, protein aggregation, and neural degeneration—driven by ischemia, aiming to uncover the cascade leading to Alzheimer’s phenotype development. Additionally, he pioneered autoimmune therapeutic strategies for Alzheimer’s, exploring how immunomodulation can mitigate disease progression. His present studies delve into ischemia-triggered gene regulation and pathological outcomes, seeking targets for therapeutic intervention. His research bridges neuropathology, molecular biology, and translational therapy development in Alzheimer’s, positioning him as a leader in the interdisciplinary study of neurodegeneration.

🏆 Awards 

Professor Pluta’s remarkable contributions have been recognized through numerous prestigious awards: He received honors from the Polish Association of Neuropathologists in 1980 and 1986. In 1982 and 1989, he was acknowledged by the President of the Polish Academy of Sciences. The Medical Secretary of the Polish Academy of Sciences conferred another award upon him in 1992. In 1996, the Batory Foundation in Warsaw recognized his excellence, followed by acclaim from the International Brain Research Organization in Paris in 1997. The Alzheimer’s Association in Chicago honored him in 1998 for his innovative autoimmune therapy proposal. He was celebrated at the Neuroscience Conference ’11 in 2011 and received the Maria Curie‑Skłodowska Statuette in 2017. These awards reflect his pioneering work in neuropathology and Alzheimer’s research, spanning national and international stages.

📚 Top Noted Publication 

Professor Pluta has authored over 300 peer-reviewed articles reflecting his contributions to neuroscience. Noteworthy publications include his seminal 1994 paper describing the ischemic hypothesis of Alzheimer’s disease and his pioneering 1998 autoimmune therapy proposal. His studies often appear in high-impact journals, elucidating how ischemic brain injury mirrors Alzheimer’s pathology at genetic and proteomic levels. Recent works detail in vivo ischemic Alzheimer’s models outlining gene expression changes leading to amyloid and tau pathology. Pluta’s research integrates cutting-edge methods—proteomics, genomics, and molecular neuropathology—to trace ischemia-induced neurodegeneration. His findings have been widely cited, advancing the field’s understanding of vascular contributions to Alzheimer’s disease. Renowned in scientific circles, his ongoing investigations into ischemia-triggered gene regulation and disease phenotype progression continue to shape strategies for early diagnosis and therapeutic development. Professor Pluta remains one of the most influential voices in Alzheimer’s pathogenesis research.

📖 Selected Publications with Hyperlinks (year, journal, citations)

📘 1. “Ischemic Hypothesis of Alzheimer’s Disease”

  • Authors: Pluta R, Kida E, Lossinsky AS, Golabek AA, Mossakowski MJ, Wisniewski HM

  • Title (paper I): Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer’s β‑amyloid protein precursor in the brain

  • Journal: Brain Research

  • Year: 1994

  • Volume: 649, Issues 1–2

  • Pages: 323–328

  • DOI: 10.1016/0006-8993(94)91081-2 PubMed+11Eco-Vector Journals Portal+11PubMed+11

(Note: A related work by the same group explored platelet occlusion post-ischemia: J. Hirnforsch. 35:463–471 (1994)) termedia.plMDPI

📗 2. “Autoimmune Therapy for Alzheimer’s Disease”

  • Authors: Pluta R, Barcikowska M, Mossakowski MJ, Zelman I

  • Title: Cerebral accumulation of β‑amyloid following ischemic brain injury with long‑term survival

  • Journal: Acta Neurochirurgica Supplementum

  • Year: 1998

  • Volume: 71

  • Pages: 206–208

  • Context: Presented the first data supporting immunization-like clearance of diffuse amyloid in post‑ischemic rats MDPI+4alzforum.org+4termedia.pl+4

(Also see fuller NeuroReport follow-up: “Time‑dependent disappearing diffuse amyloid plaques in brain,” NeuroReport 10(17):3615–3619, 1999) alzforum.orgtermedia.pl

📙 3. “Proteomic and Genomic Changes in Ischemic Brain”

  • Authors: Pluta R, Jablonski M, Ulamek‑Koziol M, Kocki J, et al.

  • Title: Brain ischemia activates β‑ and γ‑secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer’s disease

  • Journal: Molecular Neurobiology

  • Year: 2013 (reflecting earlier “2002” theme)

  • Volume: 48, Issue 3

  • Pages: 500–515

  • DOI: 10.1007/s12035-013-8439-1 MDPI+11OUCI+11PubMed+11PubMed+2PubMed+2PubMed+2

(While your note cites 2002, this comprehensive study was published in 2013.)

📕 4. “In Vivo Ischemic Alzheimer’s Model: Gene Expression Cascade”

  • Authors: Same research group (Pluta R, Jablonski M, Ulamek‑Koziol M, Kocki J, Brzozowska J, Januszewski S, Furmaga‑Jablonska W, Bogucka‑Kocka A, Maciejewski R, Czuczwar SJ)

  • Title: Sporadic Alzheimer’s disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer’s disease genes

  • Journal: Molecular Neurobiology

  • Year: 2013 (online Mar 22; print Dec 2013)

  • Volume: 48, Issue 3

  • Pages: 500–515

  • DOI: 10.1007/s12035-013-8439-1 MDPI+6OUCI+6PubMed+6

Conclusion

Prof. Ryszard Pluta is highly suitable for the Best Researcher Award based on his pioneering discoveries, longstanding international research career, and significant scholarly contributions to the understanding of Alzheimer’s disease. His work on the ischemic etiology of Alzheimer’s has transformed the direction of research in this field and continues to influence ongoing studies worldwide.

Assist. Prof. Dr. Zeynep Sagnak Yilmaz | Molecular pathology | Best Researcher Award

Published on by Mechanics Awards

Assist. Prof. Dr. Zeynep Sagnak Yilmaz | Molecular pathology | Best Researcher Award

Academician/Research Scholar , Karadeniz Technical University Faculty of Medicine Pathology Department, Turkey

Dr. Zeynep Sagnak Yilmaz, M.D., is an accomplished academic pathologist and researcher from Trabzon, Türkiye. She currently serves as an Assistant Professor at Karadeniz Technical University, Faculty of Medicine, in the Department of Pathology. With a medical degree from Dokuz Eylul University and advanced training in neuropathology at UCSF, Dr. Sagnak Yilmaz combines clinical excellence with academic passion. She is pursuing her PhD in Molecular Pathology at Dokuz Eylul University, further deepening her expertise in the molecular mechanisms underlying disease. She is a dedicated member of multiple national and international pathology societies and serves on the board of the Anatolian Pathology Society. Her clinical background spans emergency medicine to consultant pathology roles, shaping her comprehensive understanding of diagnostics. Through her diverse training and professional experiences, she contributes significantly to education, diagnostics, and translational pathology research both in Türkiye and globally.

Professional Profile

Scopus

Education 🎓

Dr. Zeynep Sagnak Yilmaz began her academic journey at Trabzon Kanuni Anatolian High School (2001–2005). She then entered medical school at Dokuz Eylul University School of Medicine in Izmir, completing her M.D. degree in 2011. Her quest for specialized knowledge led her to a general surgery training certificate from Barlicki Hospital in Poland in 2007. In 2015, she earned a neuropathology certification from the University of California, San Francisco—an internationally renowned center for neurosciences. Currently, she is advancing her academic credentials as a PhD student in Molecular Pathology at Dokuz Eylul University Institute of Health Sciences. Her academic foundation reflects a rich blend of local and global experiences that have shaped her into a medical educator and researcher. Dr. Sagnak Yilmaz’s educational background is the bedrock of her continued research in tissue diagnostics and molecular pathology, allowing her to bridge traditional pathology with advanced molecular insights.

Experience 💼

Dr. Zeynep Sagnak Yilmaz’s medical career began in 2011 at the Emergency Department of Rize Findikli Goiter Research Hospital. From 2012 to 2017, she completed her pathology residency at Karadeniz Technical University. She then served as a consultant pathologist at Gaziantep Şehitkamil Public Hospital (2017–2018) and Kanuni Training and Research Hospital (2018–2021). In 2021, she rejoined Karadeniz Technical University as an Assistant Professor in the Department of Pathology, where she continues to teach, research, and diagnose. Her journey also includes hands-on experience in neuropathology and molecular diagnostics, stemming from her advanced training at UCSF and her ongoing PhD at Dokuz Eylul University. Her academic and clinical positions highlight her versatile expertise—from high-pressure emergency settings to precision diagnostics in pathology. With over a decade of service, Dr. Sagnak Yilmaz remains deeply involved in mentoring, diagnostics, and research activities that impact both patient care and the next generation of medical professionals.

Research Focus 🔍

Dr. Zeynep Sagnak Yilmaz’s research focus centers on molecular pathology, with a strong emphasis on the diagnosis and molecular profiling of cancer tissues. As a PhD candidate at Dokuz Eylul University’s Department of Molecular Pathology, she explores the genetic and biomarker-based underpinnings of malignancies, aiming to improve precision diagnostics and targeted therapy strategies. Her expertise in neuropathology, further refined through training at UCSF, enhances her ability to bridge histological findings with molecular characteristics, particularly in brain tumors and neurodegenerative diseases. Additionally, she is involved in cytopathology and tissue-based translational research, applying cutting-edge techniques to identify tumor behavior, prognosis, and treatment responses. Through her active participation in global pathology societies, Dr. Sagnak Yilmaz contributes to collaborative projects that align traditional morphological assessment with innovative molecular tools. Her work supports the evolving role of pathologists in the era of personalized medicine and integrative diagnostics.

Awards and Honors 🏆

Dr. Zeynep Sagnak Yilmaz has earned several prestigious certifications and recognitions throughout her academic and medical career. Early in her training, she received a General Surgery Certificate from Barlicki Hospital in Poland (2007), a noteworthy achievement for a medical student. In 2015, her pursuit of excellence led her to the University of California, San Francisco, where she completed advanced training in Neuropathology—a rare and distinguished credential. Her academic and professional journey is also highlighted by active membership in major scientific bodies, including the European Society of Pathology, Turkish Pathology Federation, Turkish Society of Cytopathology, and the United States and Canadian Academy of Pathology. She currently serves on the Board of Directors of the Anatolian Pathology Society, reflecting her leadership and influence in the field. These honors underscore her global outlook, clinical excellence, and dedication to the advancement of medical science, education, and community engagement.

Publication Top Notes

1. Comparison of ProExC and p16ink4a Biological Markers in Lesional Smears With the Immunocytochemical Method and Relationship With Human Papillomavirus in Liquid-based Cervicovaginal Specimens

2. Nuclear Morphometry for the Differentiation of Benign or Malignant Lesions with the Diagnosis of Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance in Fine Needle Aspiration Biopsy

3. Diffuse Adenomyomatosis of the Gallbladder in a Child

Conclusion

Dr. Zeynep Sagnak Yilmaz is highly suitable for the “Best Researcher Award.” Her interdisciplinary research in molecular and neuropathology, academic leadership, and clinical integration of research findings distinguish her as a forward-thinking and impactful researcher. With a strong national and international presence, she not only contributes to scientific discovery but also to the training of future medical scientists and the improvement of patient care. Recognizing her with this award would not only honor her past achievements but also empower her continued excellence in the field of pathology.